Please assess the completion status of the following clinical trial:

Trial Title: Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* best corrected visual acuity in both eyes of at least +0.7~* six-month documented history of dry eye disease~* at least mild severity in 2 of the 4 dry eye symptoms~* unanesthetized Schirmer score of less than or equal to 7mm~* corneal fluorescein staining of greater than or equal to 4 (out of 15)~Exclusion Criteria:~* nasally stimulated Schirmer score of less than 3mm in subjects with an initial Schirmer score of 0mm~* ongoing contact lens wear~* current topical ophthalmic medication use

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).